Sign In
Buy TBPH
$15.92
+0.340 (+2.18%)
At Close: Jun 03, 2026
Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates
06:54pm, Monday, 07'th Aug 2023
Theravance Biopharma (TBPH) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.04 per share a year ago.
Theravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023
06:00am, Monday, 24'th Jul 2023
DUBLIN , July 24, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2023 financial results and provide a business update after market close on Monday, Augu
Why Is Theravance Bio (TBPH) Down 3.8% Since Last Earnings Report?
12:34pm, Wednesday, 07'th Jun 2023
Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock?
Theravance Biopharma: Activist Pressure Might Lead To Substantial Capital Return
04:45am, Wednesday, 03'rd May 2023
Theravance Biopharma has recently come under pressure from a reputable activist investor, Irenic Capital. The activist is pushing the company to initiate a large capital return and launch a strategic
Theravance Biopharma to Report First Quarter 2023 Financial Results on May 8, 2023
06:00am, Monday, 24'th Apr 2023
DUBLIN , April 24, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2023 financial results and provide a business update after market close on Monday, May 8
Theravance Biopharma to Participate in an Upcoming Investor Conference
06:00am, Monday, 10'th Apr 2023
DUBLIN , April 10, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17 at 3:45 pm ET (12:45 pm PT/8
Theravance Biopharma to Participate in an Upcoming Investor Conference
06:00am, Thursday, 02'nd Mar 2023
DUBLIN , March 2, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in the Respiratory/Infections Corporate Panel Discussion at the 43rd Annual TD Cowen Health Care Con
Theravance's (TBPH) Q4 Earnings and Revenues Miss Estimates
03:49pm, Tuesday, 28'th Feb 2023
Thervance's (TBPH) fourth-quarter loss wider than expected. Revenues decline year over year.
Theravance Biopharma Inc. (TBPH) Q4 2022 Earnings Call Transcript
09:25pm, Monday, 27'th Feb 2023
Theravance Biopharma Inc. (NASDAQ:TBPH ) Q4 2022 Results Conference Call February 27, 2023 5:00 PM ET Company Participants Rick Winningham - Chairman and Chief Executive Officer Rhonda Farnum - Senior
Theravance Biopharma (TBPH) Reports Q4 Loss, Lags Revenue Estimates
07:34pm, Monday, 27'th Feb 2023
Theravance Bio (TBPH) delivered earnings and revenue surprises of -5% and 19.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Drug, Biotech Stocks Poised to Beat Q4 Earnings Estimates
09:02am, Thursday, 23'rd Feb 2023
We look at a few drug/biotech companies, TBPH, FGEN, AUPH, CYTK, which are poised to beat on earnings in the fourth quarter.
Theravance Biopharma to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
06:00am, Tuesday, 21'st Feb 2023
DUBLIN , Feb. 21, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its fourth quarter and full year 2022 financial results and provide a business update after market close on
New Strong Buy Stocks for February 14th
09:02am, Tuesday, 14'th Feb 2023
INSP, ALK, SSKN, NVO and TBPH have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2023.
Theravance Biopharma to Participate in an Upcoming Investor Conference
06:00am, Thursday, 09'th Feb 2023
DUBLIN , Feb. 9, 2023 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the SVB Securities Global Biopharma Conference on Wednesday, February 15 at 8:00
Theravance Biopharma, Inc. (TBPH) Q3 2022 Earnings Call Transcript
11:34pm, Monday, 07'th Nov 2022
Theravance Biopharma, Inc. (NASDAQ:TBPH ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Rick Winningham – Chairman and Chief Executive Officer Rhonda Farnum – S
